These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29742798)

  • 21. Latent process model of the 6-minute walk test in Duchenne muscular dystrophy : A Bayesian approach to quantifying rare disease progression.
    Lennie JL; Mondick JT; Gastonguay MR
    J Pharmacokinet Pharmacodyn; 2020 Feb; 47(1):91-104. PubMed ID: 31960231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
    Mazzone E; Vasco G; Sormani MP; Torrente Y; Berardinelli A; Messina S; D'Amico A; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Bonfiglio S; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Gasperini S; Previtali S; Napolitano S; Martinelli D; Bruno C; Vita G; Comi G; Bertini E; Mercuri E
    Neurology; 2011 Jul; 77(3):250-6. PubMed ID: 21734183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy.
    Kempen JC; Harlaar J; van der Kooi AJ; de Groot IJ; van den Bergen JC; Niks EH; Verschuuren JJ; Brehm MA
    Neuromuscul Disord; 2014 Mar; 24(3):216-21. PubMed ID: 24365209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy.
    Mercuri E; Signorovitch JE; Swallow E; Song J; Ward SJ; ;
    Neuromuscul Disord; 2016 Sep; 26(9):576-83. PubMed ID: 27423700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy.
    Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD
    J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.
    Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K
    Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boys With Duchenne Muscular Dystrophy: 1-Year Locomotor Changes in Relation to a Control Group.
    Martini J; Caromano FA; Carvalho EV; Goya PA; Hayasaka RM; Nakazune S; Fávero FM; Voos MC
    Percept Mot Skills; 2018 Feb; 125(1):40-56. PubMed ID: 29171337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls.
    Mendell JR; Khan N; Sha N; Eliopoulos H; McDonald CM; Goemans N; Mercuri E; Lowes LP; Alfano LN;
    J Neuromuscul Dis; 2021; 8(4):469-479. PubMed ID: 33523015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the climbing up and climbing down stairs domain scores on the FES-DMD, the score on the Vignos Scale, age and timed performance of functional activities in boys with Duchenne muscular dystrophy.
    Fernandes LA; Caromano FA; Assis SM; Hukuda ME; Voos MC; Carvalho EV
    Braz J Phys Ther; 2014; 18(6):513-20. PubMed ID: 25590443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
    Forbes SC; Arora H; Willcocks RJ; Triplett WT; Rooney WD; Barnard AM; Alabasi U; Wang DJ; Lott DJ; Senesac CR; Harrington AT; Finanger EL; Tennekoon GI; Brandsema J; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Radiology; 2020 Jun; 295(3):616-625. PubMed ID: 32286193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six-Minute Walk Test.
    Hamuro L; Chan P; Tirucherai G; AbuTarif M
    CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):596-603. PubMed ID: 28643370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower Extremity Functional Outcome Measures in Duchenne Muscular Dystrophy-A Delphi Survey.
    Senesac CR; Lott DJ; Willcocks RJ; Duong T; Smith BK
    J Neuromuscul Dis; 2019; 6(1):75-83. PubMed ID: 30562905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial.
    Schiava M; McDermott MP; Broomfield J; Abrams KR; Mayhew AG; McDonald CM; Martens WB; Gregory SJ; Griggs RC; Guglieri M;
    Neurology; 2024 May; 102(10):e209206. PubMed ID: 38710006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Speed T
    Xu T; Xu K; Song Y; Zhou Z; Fu H; Xu R; Cai X; Guo Y; Ye P; Xu H
    J Magn Reson Imaging; 2023 Oct; 58(4):1270-1278. PubMed ID: 36773028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying Variability in Motor Function in Duchenne Muscular Dystrophy: UK Centiles for the NorthStar Ambulatory Assessment, 10 m Walk Run Velocity and Rise from Floor Velocity in GC Treated Boys.
    Stimpson G; Ridout D; Wolfe A; Milev E; O'Reilly E; Manzur A; Sarkozy A; Muntoni F; Cole TJ; Baranello G;
    J Neuromuscul Dis; 2024; 11(1):153-166. PubMed ID: 37980680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?
    Buckon C; Sienko S; Bagley A; Sison-Williamson M; Fowler E; Staudt L; Heberer K; McDonald CM; Sussman M
    PLoS Curr; 2016 Jul; 8():. PubMed ID: 27500011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy.
    Weng WC; Tsui PH; Lin CW; Lu CH; Lin CY; Shieh JY; Lu FL; Ee TW; Wu KW; Lee WT
    Sci Rep; 2017 Jun; 7(1):4429. PubMed ID: 28667314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timed rolling and rising tests in Duchenne muscular dystrophy ambulant boys: a feasibility study.
    Sobierajska-Rek A; Jabłońska-Brudło J; Dąbrowska A; Wojnicz W; Meyer-Szary J; Wierzba J
    Minerva Pediatr (Torino); 2024 Apr; 76(2):208-216. PubMed ID: 38639735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.